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Abstract 
People have known that autophagy plays a very important role in many 
physiological and pathological events. But autophagy role on embryonic angiogenesis 
still remains obscure. In this study, we demonstrated that Atg7, Atg8 and Beclin1 were 
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expressed in the plexus vessels of angiogenesis at chick yolk sac membrane and 
chorioallantoic membrane. Interfering with autophagy with autophagy inducer or 
inhibitor could restrict the angiogenesis in vivo, which might be driven by the disorder 
of angiogenesis-related gene expressions, and also lead to embryonic hemorrhage, 
which was due to imperfection of endothelial cell-cell junctions including abnormal 
expressions of tight junction, adheren junction and desmosome genes. Using 
HUVECs, we revealed that cell viability and migration ability changed with the 
alteration of cell autophagy exposed to RAPA or 3-MA. Interestingly, tube formation 
assay showed that HUVECs ability of tube formation altered with the change of Atg5, 
Atg7 and Atg8 manipulated by the transfection of their corresponding siRNA or 
plasmids. Moreover, the F-actin labeled cell polarity lost and β-catenin absence in 
RAPA-treated cell membrane implied intracellular cytoskeleton alteration was 
induced by autophagy level. Taken together, our current experimental data reveal that 
autophagy is really involved in regulating angiogenesis during embryo development.  
Key words: autophagy, angiogenesis, yolk sac membrane, chorioallantoic membrane, 
Atg.  
 
Abbreviation: 3-MA, 3-Methyladenine; BECN1, beclin-1; CAM, chorioallantoic 
membrane DAPI, 49-6-Diamidino-2-phenylindole; DMSO dimethyl sulfoxide; 
HUVECs, human umbilical vein endothelial cells; GFP, green fluorescent protein; 
HN, Hensen’s node; MAPILC3(LC3), microtubule-associated protein 1 light chain 3; 
mTOR, mammalian target of rapamycin; VE-Cad, VE-cadherin; RAPA, Rapamycin; 
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RT-PCR, reverse transcription PCR; YSM, yolk sac membrane; ZA, Zonula adherens. 
 
Introduction 
 The functional vascularization undergoes three major processes including 
vasculogenesis, angiogenesis and arteriogenesis, i.e., new blood vessels are formed 
and remodeled. 1 The vasculogenesis is depicted as the two successive events of 
vascularization process. Firstly, angioblasts (vascular precursors) from mesoderm 
cells migrate to form blood islands, and then primary capillary plexuses form through 
connecting the blood islands. 2 The fundamental function for blood vessels is to 
deliver O2 to all the cells round the body in order to maintain oxygen homeostasis in 
organism. Hypoxia occurs if O2 supply and demand are out of balance and the 
hypoxia could be a physiological stimulus inducing the generation of angiogenic 
cytokines such as VEGF, which binds to its cognate receptors, VEGFRs on 
endothelial cells, to stimulate the cells to facilitate the angiogenesis. 1, 3 Although 
VEGF plays a crucial role for vascularization, it is not deemed to be efficient, so that 
other growth factors/cytokines including angiopoietins (Ang), SDF-1, PDGFb and 
FGF2 etc are also involved in sprouting angiogenesis. 4, 5 However, it is noteworthy 
that the angiogenesis in adult appears to be quite different from the vasculogenesis, 
the initial embryonic vascular plexus during embryo development. One of important 
distinctions is that the formation of the initial vascular plexus during embryo 
development is not completely driven by oxygen gradients, i.e., many other 
angiogenic growth factors/cytokines are implicated in the process. 1  
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Autophagy is deemed to be a dynamic process of subcellular degradation, in 
which cell survival is under nutrient-deprived conditions. 6 In physiological conditions, 
autophagy is the process by which energy is supplied for embryonic development 
through the lysosomal degradation of cellular contents. 7 When autophagy is activated, 
some cellular components are sequestered in autophagosomes, and eventually 
degraded and fused with lysosomes for maintaining cell metabolism. 8 Thus, 
autophagy could act as a housekeeper by preventing dysfunctional protein 
accumulation in cells through removing dead or damaged organelles. 7 So far, people 
have found that autophagy-related genes (Atg) including Atg5, Atg7, and Atg8 (LC3) 
participate in the various stages of the autophagy process. 9 The importance of 
autophagy in embryo development has been confirmed by the experiment that the 
mice with either Atg5 or Atg7 mutation could survive in the embryonic period but die 
soon after birth. 10, 11 Therefore, the study on autophagy role in vertebrate 
development has been paid more and more attention at moment. Rapamycin (RAPA) 
has been employed as a pharmacological inducer of autophagy since it could provoke 
autophagy through mTOR-mediated pathway. 12 One of the other ways to promote 
autophagy is by inducing ER stress such as Tunicamycin, which is a glycosylation 
inhibitor. Another frequently-used pharmacological compound in autophagy study is 
3-MA, 13, 14 which blocks the formation of LC3-II and p62 degradation, so that it 
could inhibit ATG5-induced autophagy. 
The correlation between angiogenesis and autophagy has been gradually 
uncovered at moment. Ramakrishnan et al. reported that blocking angiogenesis with 
  5 
kringle 5 (K5), a potent angiogenesis inhibitor, could induce autophagy in endothelial 
cells by knocking down Beclin-1 and increasing apoptosis simultaneously, which is 
independent of nutritional or hypoxic stress. 15 By blocking autophagy with 3-MA or 
knocking down ATG5 with small interfering RNA (siRNA) in bovine aortic 
endothelial cells (BAECs), Du et al. demonstrated that autophagy affected 
angiogenesis in aortic endothelial cells induced by nutrient deprivation. 16 However, 
the role of autophagy on embryonic angiogenesis is still obscure. In this study, we 
employed the combination of early embryo model and HUVECs to investigate the 
role of autophagy on vascularization and its cellular mechanism during embryo 
development. 
 
Materials and methods 
Chick embryos and exposure to compounds  
Fertilized chick eggs were obtained from the Avian Farm of the South China 
Agriculture University. The eggs were incubated until the required HH stage 17 in a 
humidified incubator (Yiheng Instrument, Shanghai, China) at 38°C and 70% 
humidity.  
The chick embryos at HH9 stage were exposed to control 200μL 0.1% DMSO 
(Sigma-Aldrich, MO, USA) or 40nM of RAPA (LC Labs, USA) or 5mM of 
3-MA(3-MA; Sigma, M9281) for 7.5 days. Briefly, approximately 200 µL of DMSO 
or RAPA or 3-Methyladenine of above concentrations were carefully injected into a 
small hole made in the air chamber of the 1.5-day incubated eggs as previously 
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described. 18 The experiments were performed in triplicate with 20 eggs assigned for 
each treatment group. After the treatment, the embryos were further incubated for 7.5 
days before they were fixed with 4% paraformaldehyde for analysis of morphology 
and gene expression. 
Immunofluorescent staining 
The chick embryos were harvested after a given time incubation and fixed in 4% 
PFA overnight at 4°C. For the HUVECs, after exposure to 3-MA, RAPA or a 
combination of 3-MA and RAPA for 8 hours, the cells were fixed for 30 min in 4% 
PFA in PBS, rinsed and transferred into normal goat serum. Immunofluorescent 
staining on either whole-mount embryo or cultured cells was performed against the 
following antibodies: Atg7, Atg8, and Beclin-1. Briefly, the fixed embryos (cultured 
cells) were then incubated with Atg7 (1:200) (A2856, Sigma, USA), Atg8 (1:200, 
Sigma, L7543, USA) and Beclin-1 (1:200) (B6061, Sigma, USA), primary antibody at 
4°C overnight (whole-mount) or 36 hours (cultured cells) on a shaker. F-actin (1:2000) 
(P5282, Sigma, USA) staining was performed after normal goat serum incubation 
without the secondary antibody. Following extensive washing, the embryos/cultured 
cells were incubated with either anti-rabbit IgG conjugated to Alexa Fluor 488 or 555 
overnight at 4°C on a rocker. All the embryos/cultured cells were later counterstained 
with DAPI(4'-6-Diamidino-2-phenylindole ) (1:1000) (AMEP4650, Invitrogen, USA) 
at room temperature for 1 hour.  
RNA isolation and RT-PCR 
Total RNA was isolated from CAM or YSM of chick embryos using a Trizol kit 
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(Invitrogen, USA) according to the manufacturer’s instructions. Gene expressions 
were semi-quantitatively assessed utilizing reverse transcription-polymerase chain 
reaction (RT–PCR) as previously reported. 19 Following reverse transcription, PCR 
amplification of the cDNA was performed using chick specific primers. The primers 
sequences are provided in Supplementary Fig. S1. Briefly, 5μg amount of total RNA 
was reversely transcribed into cDNA at 42℃ for 1 hour in 20μL of reaction mixture 
containing iScript Reverse Transcriptase (BIO-RAD, Hercules, CA) with oligo (dT) 
and random hexamer primers (BIO-RAD, Hercules, CA) and followed by PCR 
amplification. PCR was carried out with 1μL of cDNA, 12.5 mL of DreamTaq Green 
PCR master mix(2X)(Thermo scientific, Foster City, California), containing 
dream-Taq DNA polymerase, dATP, dCTP, dGTP, dTTP and MgCl2, mixed with 1 
mM forward primer, 1 mM reverse primer in a total volume of 25μL. The cDNA was 
amplified using specific primers with 30 cycles at 94℃ for 30 s, an annealing 
temperature of 60℃ for 30 s, and then 72℃ for 30 s, with final incubation at 72℃ for 
7 min. The sets of primers used for RT-PCR are provided in the Supplementary Fig. 1. 
The PCR products (20 μl) were resolved using 2% agarose gels (Biowest, Spain) in 
1× TAE buffer (0.04 M Trisacetate and 0.001 M EDTA) and 10,000x GeneGreen 
Nucleic Acid Dye (TIANGEN, China) solution. The resolved products were 
visualized using a transilluminator (SYNGENE, UK), and photographs were captured 
using a computer-assisted gel documentation system (SYNGENE). 
Western blot  
Chick embryo CAM tissues or human umbilical vein endothelial cells (HUVECs) 
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after treatment were collected and lysed with CytoBuster™ Protein Extraction 
Reagent (#71009, Novagen). Total protein concentrations were assessed via a BCA 
quantification kit (BCA01, DingGuo BioTECH, CHN). Samples containing identical 
amounts of protein were fractionated by SDS-PAGE, and then transferred to PVDF 
membranes (Bio-Rad). Membranes were blocked with 5% Difco™ skim milk (BD) 
and subsequently incubated with primary and secondary antibodies, then bands of 
interest protein were visualized using the ECL kit (#34079,Thermo) and 
GeneGnome5 (SYNGENE). Gray scale of bands was analyzed using Quantity One 
software (Bio-Rad). Antibodies: LC3B(1:1000) (A2856 , Sigma, USA); Atg7 (1:1000) 
(L7543, Sigma, USA), Beclin-1 (1:500) (B6061, Sigma, USA), VEGFR2 (D5B1,Cell 
Signaling Technology, USA); HIF2α (1:400) (10P26, Boster, CHN); VEGFA (1:200) 
(990489W, Boster, CHN) and β-actin (1:2000) (60008-1-Ig, Proteintech, USA); Atg5 
(1:400) (13MK43, Boster, CHN) and Mtor (1:2000) (BS3611, Bioworld Technology, 
USA). HRP-conjugated anti-mouse IgG, HRP-conjugated anti-rabbit IgG (Cell 
Signaling Technology, USA). All primary antibodies were diluted in 5% skim milk, 
and secondary antibodies were 2000-fold diluted. 
Assessment of angiogenesis using chick YSM 
As previously described, 20 fertilized eggs were incubated for 2.5 days and then 
placed into a sterilized glass dish. The YSM containing blood vessels were orientated 
facing upward. Two silicone rings were placed directly on top of the leading edge of 
the blood vessels. To avoid developmental differences between different embryos, 
40μL of PBS with 1% DMSO (control) was introduced into the ring located on the left 
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side of the YSM. Meanwhile, 40μL of 3-MA (5mM) or RAPA (40nM) was introduced 
into the ring on the right side of the same embryo. The rings were marked with red ink 
in the control side and black ink in the experiment side to indicate the starting position 
of the YSM within the ring. The extent of growth and expansion of the blood vessel 
plexus inside the silicone rings were determined and photographed (Olympus MVX10) 
after 12 - 48 hour incubation. Ten embryos in each treatment group were examined.  
Assessment of angiogenesis using chick CAM  
As previously described, 20 chick embryos were incubated until 7.5 days when the 
chorioallantoic membrane (CAM) is well developed. The embryos were treated with 
200μL of 3-MA (5mM) or RAPA (20nM, 40nM, 80nM) or PBS (DMSO 0.1%) or 
tunicamycin (1μg/mL) for 48 hours and all surviving embryos were harvested for 
analysis. The CAM and accompanying blood vessels in the control and 3-MA- or 
RAPA-treated embryos were photographed using a Canon Powershot SX130 IS 
digital camera (12.1M Pixels). Ten embryos in each experimental group were 
examined. The CAMs from eight embryos in each group were embedded, sectioned 
and stained with hematoxylin & eosin. The BVD and microvasculature were 
quantified and analyzed as described above for assessing angiogenesis in YSM. The 
CAMs were also harvested for different biochemical assays as described below. 
Assessment of blood vessel integrality 
 The assay of Evans blue (EB) (Sigma, US) leakage was used to evaluate blood 
vessel disruption following 40nM RAPA or 5mM 3-MA or 0.1% DMSO treatment as 
described previously. The EB measurement was performed according to the previous 
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study by Lenzser. 21 Briefly, 2 % EB (4 mL/kg) was injected via YSM. At 2h after EB 
injection, YSM and CAM were harvest. The embryos for detecting the Evans blue 
contents were reperfused with PBS before harvest. YSM samples were then 
homogenized by 80% trichloracetic acid and centrifuged. Then the supernatants were 
mixed with ethanol (1:4). The absorbance of supernatants was measured at 630 nm 
with microplate reader (Biotek, ELX800, US).  
For YSM, they were fixed by 4% paraformaldehyde overnight, and photographed 
using stereoscope fluorescence microscope (Olympus MVX10) with imaging 
software (Image-Pro Plus 7.0). 
Photograph 
After immunofluorescent staining, the whole-mount embryos were photographed 
using stereoscope fluorescence microscope (Olympus MVX10) with imaging 
software (Image-Pro Plus 7.0). The sections of the embryos were photographed using 
an epi-fluorescent microscope (Olympus IX51, Leica DM 4000B) at 200 or 4006 
magnification with the Olympus software package Leica CW4000 FISH. 
Transmission electron microscopy 
The treated chick embryos were fixed with 2.5% glutaral in 0.1 M PBS for 2 
hours, and then yolk sac membranes (YSM) were dissected. The samples were sent to 
the TEM Laboratory of Sun Yat-sen University. The embedding, ultrathin sectioning 
and staining were performed by professional technicians and examined using a Tecnai 
G2 Spirit Twin (FEI, USA). 
Cell lines and culture 
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Human umbilical vascular endothelialcells (HUVECs) were a kindly gift from 
Zhi Huang’s lab, and cultured in Dulbecco's modified Eagle's medium (DMEM) 
medium (Gibco, shanghai, China) supplemented with 10% fetal bovine serum (FBS), 
and incubated at 37 °C and 5% CO2 
Migration assay  
HUVECs were seeded in 6-well plates with DMEM (10% FBS) medium. At 
confluency, a wound was induced by scratching the monolayer with a 10-μl pipette tip. 
The cells were then washed 3 times with sterile PBS. HUVECs were incubated in 
serum-free DMEM medium with 5mM 3-MA, 40nM RAPA or 0.1% DMSO，under 
5% CO2 conditions. Images were acquired at 12 h, 24h, 36h and 48h post‑scratching. 
At least 3 wells were analyzed in each treatment group and the images were taken 
using an inverted microscope (Nikon Eclipse Ti-U, Japan). 
Cell transfection 
siRNA against ATG7 or control were purchased from Ribo Bio. Cells were 
transfected with 25 nM siRNAs using Lipofectamine 2000. For overexpression, cells 
were transfected with 14μg of control vector pIRES2-EGFP, pCMV-Myc or 
pEGFP-C2, and experiment groups with pIRES2-EGFP-ATG5, pCMV-Myc-ATG7 
or pEGFP-C2-LC3 using Lipofectamine 2000. pIRES2-EGFP-ATG5
（ NM_001286106.1）  plasmids was purchased from Hanbio Biotechnology. 
pCMV-Myc-ATG7（Genbank：BC000091） and pEGFP-C2-LC3 （Genbank：
BC067797）plasmids were kindly gifts from Toren’s lab. The experiment procedure 
was according to the specification of Lipofectamine 2000. Briefly, For each well of 
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6-plate, 15μL Lipofectamine® 2000 Reagent was added into 150μL serum-free 
DMEM medium. SiRNA or plasmids were added into 150μL serum-free DMEM 
medium. Mixed them and incubated for 5 minute. At last, added 250μL mixture into 
each well. After 24h, the transfected cells were photographed using an inverted 
microscope (Nikon Eclipse Ti-U, Japan) then it used for subsequent experiments 48h 
later. 
Tube assay 
The tube formation assay was performed as follows. Each well of 12-well plates 
were coated with 200μL of the mixture of Matrigel (BD Biosciences，USA) and 
serum-free DMEM medium and incubated at 37℃ for 30 min to promote gelling. 
HUVECs were resuspended in DMEM medium (serum concentration 10%) and added 
to each well，and add the DMEM medium each well in a final volume of 1ml. After 
24h, the plates were fixed with 4% paraformaldehyde. Then the images were taken 
using an inverted microscope (Nikon Eclipse Ti-U, Japan) at the middle version of the 
each well. Each well was tested in triplicate and each experiment was repeated at least 
three times. The average number of tubules was calculated from examination of six 
separate microscopic fields. Tube formation in the presence of 3-MA or RAPA, or a 
combination of 3-MA and RAPA or transfection group were compared to tube 
formation in media with 0.1% DMSO as control or the control vector. 
Data analysis 
Statistical analysis for all the experimental data generated was performed using a 
SPSS 13.0 statistical package program for windows. The data were presented as mean 
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± SD. Statistical significance were determined using paired T pest, independent 
samples T test. *p<0.05, **p<0.01 and ***p<0.01 indicate statistically significance 
between control and drug-treated groups. 
The diagram of mechanism of autophagy on angiogenesis was drawn by Pathway 
Builder Tool software. 
 
Results 
The autophagy-related genes are expressed in chick YSM and CAM during embryo 
development. 
Atg7, Atg8 and Beclin1 are deemed to be the genes related to autophagy activities. 
22 In this study, we demonstrated that they were all strongly expressed in the 
developing vessel plexuses in yolk sac membranes (YSM), which could not only seen 
in whole-mount immunofluorescent staining against Atg7, Atg8 and Beclin1
（BECN1） (Fig. 1A-C), but also obviously seen in the transverse sections of those 
YSM tissues (Fig. 1A1-C1, A2-C2). To further confirm this observation, we 
performed Atg7 and Atg8 immunofluorescent staining on chorioallantoic membrane 
(CAM) again since it was full of newborn blood vessels as well. From the transverse 
sections of CAM tissues, we could see that both of Atg7 and Atg8 were apparently 
expressed in the epithelial cells (Fig. 1D-E, D1-E1, D2-E2). It suggests that 
autophagy is probably involved in the angiogenesis during embryo development.  
The disturbance of autophagy causes angiodysplasia in developing chick embryos. 
To investigate whether or not autophagy wasz implicated in angiogenesis in 
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embryo development, we exposed early chick embryos for 7.5 days with either 40nM 
RAPA or 5mM 3-MA, which could induce or inhibit autophagy respectively (Fig. 
2B-B2, C-C2). 13, 23 The embryos treated with 0.1% DMSO acted as control group 
(Fig. 2A-A2). In terms of the appearance of embryos, we could observe that there is a 
lot of hemorrhage in the embryos that was treated with either RAPA (n=8/16) (Fig. 2B) 
or 3-MA (n=4/16) (Fig. 2C) in comparison to the control embryos (Fig. 2A). 
Interestingly, we found that these hemorrhage was probably lack of integraty of blood 
vessels in the RAPA- and 3-MA-treated embryos compared to control one as 
schematically shown in Fig. 2A2-C2, which was based on the observations for 
transverse sections of those embryos (Fig. 2A1-C1). The hemorrhage phenotype dose 
actually not only exists in head region but also in trunk region of embryos treated with 
either RAPA (n=12/16) or 3-MA (n=6/16) (Fig. 2D). Electronic microscopy showed 
that the numbers of autophagosome increased in RAPA group while decreased in 
3-MA group (Fig. 2E-G1), which suggests that the imperfection of blood vessels was 
associated with the alterations of cell autophagy level.  
The disturbance of autophagy with autophagy activator or inhibitor affects the 
angiogenesis in chick YSM. 
Chick YSM was employed to further study the role of autophagy on angiogenesis 
through disturbing autophagy with inducer or inhibitor since YSM had been mature 
angiogenesis model to investigate embryonic angiogenesis in our laboratory as 
previously described. 20, 24-27 Compared with the extension of leading edges of vessel 
plexuses in control embryos (Fig. 3A-A3), the extension of vessel plexuses in 
  15 
3-MA-treated YSM (Fig. 3C-C3) was much slower while significantly faster in 
RAPA-treated YSM (Fig. 3B-B3), suggesting 3-MA treatment inhibited the 
angiogenesis and RAPA treatment promoted angiogenesis in YSM. The density of the 
blood vessel in RAPA treated group was 0.33±0.02 (n=6, P<0.001), which was 20% 
higher than in the control group (0.27±0.02, n=6), while it was 26% reduced in the 
3-MA treated group (0.20±0.03, n=6) (P<0.01) (Fig. 3G). Meanwhile, the blood 
numbers increased in presence of RAPA (7.00±1.059, n=12) (P<0.05) and reduced in 
presence of 3-MA (2.50±0.548, n=12) (P<0.001) (Fig. 3D-F, H) compared with the 
control (4.67±0.516, n=12), which also implied the alteration of angiogenesis in 
presence of 3-MA/RAPA. Since the angiogenesis in YSM was not only presented in 
the plane extension of vessel plexuses but also into yolk sac, so that we could see the 
blood vessel depths became deeper when exposed to RAPA (525.76±108.44μm, n=6) 
(P<0.05) and became shallower when exposed to 3-MA (285.88±37.18μm, n=6) 
(P<0.01) compared with the control (407.75±43.90μm, n=6) (Fig. 3D1-F1, I). Next, 
the angiogenesis-related gene expressions in YSM, following the treatment of RAPA 
or 3-MA, were determined by using RT-PCR (Fig. 3J). The up-regulated genes 
comprised HIF 1ɑ, HIF 2ɑ, ANG1, ANG2, VE-cadherin (VE-Cad), FGF2, TEK, 
VEGFR1, VEGFR3 following the treatment of RAPA (Fig. 3J). And in presence of 
3-MA, the genes of down-regulated expressions included HIF 1ɑ, HIF 2ɑ, ANG1, 
ANG2, FGF2, VEGFR1, VEGFR3 and others not changed dramatically (Fig. 3J). 
Compared with the control group, VE-Cad, VEGFA, VEGFR1, VEGFR2, VEGFR3, 
HIF 1α, HIF 2α, ANG1, ANG2, TEK and FGF2, the grey value of them in RAPA 
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group were significantly difference. However, in 3-MA group, the grey value of 
VE-Cad, VEGFR1, VEGFR3, HIF 1α, HIF 2α, ANG1, ANG2, TEK and FGF2 were 
significantly different, while VEGFA and VEGFR2 were not significantly different. 
(Supplementary Fig. 2). Those data suggest that any disturbance for autophagy 
homeostasis could lead to angiogenesis disorder.   
The disturbance of autophagy with autophagy activator or inhibitor affects the 
angiogenesis in chick CAM. 
To verify the observation above in chick YSM model, chick CAM, another 
angiogenesis model in early chick embryo development, was employed to determine 
the role of autophagy on angiogenesis again (Fig. 4). Likewise, we found that the 
blood vessel density in chick CAM was promoted following the exposure to 40nM 
RAPA (0.113 ±0.023 n=6) (P<0.05) compared with the control (0.100±0.023, n=6) 
(Fig. 4A-B, 4A1-B1, 4D). In contrast, 5mM 3-MA treatment (0.086±0.024, n=6) 
(P<0.05) could promote the blood vessel density in CAM compared with control 
(0.100±0.023, n=6) (Fig. 4A-C, 4A1-C1, 4D). Actually, RAPA showed the simulative 
effect of angiogenesis with a dose-dependent manner from 20nM to 80nM 
(0.057±0.023, 0.0933±0.0226, 0.0819±0.0145, n=8), but maximum effect on blood 
vessel density appeared at the concentration of 40nM (0.0933±0.0226, n=8) (P<0.05) 
(Supplementary Fig. 3A-D, A1-D1, A2-D2, E), and so was the data of the blood 
vessel diameters (Supplementary Fig. 3A3-D3). Therefore, the concentration of RAPA 
was chosen to be 40nM in this study. In addition, the alteration of blood vessel 
diameters in presence of RAPA (150.9±38.3μm, n=24) (P<0.001) or 3-MA 
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(46.7±15.7μm, n=24) (P<0.01) compared to the control (70.6±36.6μm, n=24) were 
presented in the same tendency as well (Fig. 4E).  
Western blot data showed that the ratio of LC3-II/LC3-I dramatically increased 
following the treatment of RAPA (2.869±0.0823, n=3) (P<0.001) and reduced 
following the treatment of 3-MA (0.187±0.008, n=3) (P<0.01) compared to the 
control group (0.280±0.008, n=3) (Fig. 4F), suggesting that the autophagy 
homeostasis was interrupted by the exposure to 3-MA or RAPA in chick CAM. 
Meanwhile, RT-PCR data indicated that RAPA treatment up-regulated the expressions 
of HIF 2α, ANG1, TEK, VE-Cad, VEGFA, FGF2, VEGFR1 and VEGFR3, while 
3-MA treatment down-regulated the expressions of ANG1, ANG2, VEGFA, TEK, 
FGF2, VE-Cadherin, VEGFA, VEGFR1 and VEGFR3 in the same tissues of chick 
CAM (Fig. 4G). Compared to the control group, the grey value of RAPA group of 
VE-Cad, VEGFA, VEGFR1, VEGFR2, VEGFR3, HIF 2α, ANG1, TEK and FGF2  
were significantly different, while ANG2 was not significantly different. However, the 
3-MA group of VE-Cad, VEGFA, VEGFR1, VEGFR2, VEGFR3, HIF 2α, ANG1, 
ANG2, TEK and FGF2 were significantly different. (Supplementary Fig. 4). It 
suggests that autophagy disturbance is probably involved in the angiogenesis disorder 
following the treatment of 3-MA or RAPA.  
The integrality of blood vessels is damaged by the autophagy disturbance with the 
treatment of 3-MA or RAPA. 
To investigate if the integrity of blood vessels was destroyed by the alteration of 
autophagy, we carried out the Evans blue perfusion experiments in chick YSM model. 
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The result showed that many leaks were seen in the vessel plexus of YSM treated with 
either RAPA or 3-MA as indicated by arrows (Fig. 5A-C1). And the fluorescent 
assessment of Evans blue demonstrated that more Evans blue accumulated in the 
tissues treated with both RAPA and 3-MA (Fig. 5D). The electronic microscopy 
showed that the more cleft of zonula adheren (ZA), one kind of adherens junctions, 28 
appeared in both RAPA and 3-MA-treated YSM vessels in comparison with control 
one (Fig. 5E-G), indicating the lose of endothelial cell integrity following the 
interference of autophagy. Furthermore, β-catenin expression dropped at embryonic 
blood vessel endothelial cells in presence of 3-MA and RAPA (Fig. 5H-J). RT-PCR 
data displayed that RAPA treatment reduced the expressions of Claudin-5, Occludin, 
ɑ-catenin, P120, and increased the expressions of Vinculin, Par3; 3-MA treatment 
increased the expressions of Par3, and decreased the expressions of Claudin-5, 
ɑ-catenin, P120; for the other tight junction genes, adheren junction genes and 
desmosome genes (Claudin-1, Claudin-12, ZO1, ZO2, CGN, Plakoglobin, 
Desmoplakin), neither  autophagy inducer nor autophagy inhibitor affected their 
expressions (Fig. 5J).  
The HUVEC vitality reduces after autophagy disturbance with exposure to 3-MA or 
RAPA.  
 To further investigate the cellular mechanism of autophagy role on angiogenesis, 
we carried out LC-3 immunofluorescent staining on the in vitro 2-hour cultured 
human umbilical vein endothelial cells (HUVECs) in presence of RAPA or RAPA + 
3-MA (Fig. 6A-C, A1-C1). The LC3 was not strongly expressed in HUVECs in 
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control group (Fig. 6A-A1); LC3 expression was dramatically upgraded by the 
exposure of RAPA (40nM) (Fig. 6B-B1) and the increased LC3 expression induced by 
RAPA exposure was inhibited by adding 3-MA (5mM) in the culture medium (Fig. 
6C-C1). The expressions of Atg7, LC-3I, LC-3II and Beclin-1 at different cultured 
time point (2, 4, 8 hours) were determined using western blot (Fig. 6D-E). The results 
showed that RAPA treatment increased Atg7 and Belcin-1 expression, and decreased 
mTOR and P62 expressions (Fig. 6D), meanwhile, the 3-MA treatment inhibited Atg7 
and Beclin-1 gene expressions, and increased mTOR and P62 expressions (Fig. 6E) 
with a time-dependent manner. On the expression of LC3II and LC3I, we could 
concluded that in RAPA treated group the gray value of LC3II/LC3I increased 
(0.567±0.057, 1.353±0.051, 0.903±0.049, n=3) (P<0.01 or 0.05) than the control at 
0-hour (0.777±0.057, n=3), while that decreased in the treatment of 3-MA 
(0.108±0.004, 0.018±0.002, 0.600±0.010, n=3) (P<0.01) and decreased prominently 
in 4 hour, compared to control (1.007±0.030, n=3) (Fig. 6E). 
 After confirming the correlation between autophagy and angiogenesis in 
HUVECs, we determined the HUVECs vitality using scratch test in presence of 3-MA 
or RAPA （n=7）(Fig. 7). We could see that following the treatment RAPA in 12h, 24h, 
48h promoted the cell migration distance toward midline or cell proliferation along 
with the extension of culture time in comparison to control (Fig. 7A-A3, B-B3, D-E); 
3-MA treatment inhibited the cell migration distance toward  midline or cell 
proliferation along with the extension of culture time in comparison with control (Fig. 
7A-A3, C-C3, D-E). The number of the migrated cells toward the midline in RAPA 
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treated group in 12h, 24h and 48h, compared to the control, is increased significantly . 
And the number of the migrated cells toward the midline in 3-MA treated group   
compared to the control is reduced significantly. And the Western blot data showed 
that expressions of HIF 2ɑ, VEGFR2 and VEGFA were suppressed by the exposure of 
3-MA and RAPA for 8h. These data indicated that interference of autophagy indeed 
affected HUVEC vitality.  
The overexpression or knock-down of autophagy genes dramatically influence on 
the tube formation of HUVECs in vitro. 
 To further explore the role of autophagy on angiogenesis, we employed the 
HUVECs to carry on the tube formation experiment following the manipulating the 
Atg5, Atg7, Atg8 expression level by transfection of siRNA or plasmids. The tube 
formation assay showed that the overexpression of Atg5 with plasmids caused the less 
tube formation compared to control (Fig. 8A-D). Down-regulation of Atg7 or 
overexpression of Atg7 with siRNA/plasmids, suppressed the tube formation while 
the western blot confirmed the knock-down/overexpression worked (Fig. E-I). 
Overexpression of Atg8 with plasmids (approved by western blot) restricted the tube 
formation (Fig. 8J-M). Here, we repeated the in vitro experiment, tube formation, with 
the treatment of RAPA/3-MA in HUVECs, and obtained the suppressed effect for tube 
formation, and partially rescued when combination application of RAPA and 3-MA 
(Fig. 8N-R). Eventually, we determined F-actin expression in presence of 
RAPA/3-MA since F-actin is cytoskeleton and it is certainly associated with the 
cell-cell junctions and cell migration. The results showed that F-actin labeled 
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HUVECs lost their polarities in presence of RAPA/3-MA compared to control (Fig. 
9A-C). After treatment of RAPA/3-MA the expression of β-catenin dropped and was 
lost at HUVECs membranes as indicated by arrows (Fig. 9D-F). The in vivo and in 
vitro experiment with autophagy expression level manipulation further indicated that 
there was a close correlation between autophagy level and angiogenesis.  
 
Discussion 
Avian and mouse vertebrate models are often employed to extrapolate from animal 
studies to explore gene functions during human fetal development. Utilizing the 
characteristics that angiogenesis is easily observed at chick yolk sac membrane (YSM) 
and chorioallantoic membrane (CAM) model, we firstly performed immunostaining 
against Atg7, Atg8 and Beclin1 29 and demonstrated that all of those 
autophagy-related genes were expressed there (Fig. 1), implying the possibility that 
autophagy is involved in the angiogenesis process. Moreover, the hemorrhage 
phenotypes occurred when the developing chick embryos were exposed to either 
rapamycin (RAPA, autophagy inducer) or 3-MA (autophagy inhibitor) (Fig. 2A-D), 
which work well by the electronic microscopy examination of autophagosome (Fig. 
2E-G1). The histological analysis showed that the hemorrhage was probably due to 
the imperfection of capillary endothelium (Fig. 2A1-C2). To some extent, those 
observations are similar to the report on pathological angiogenesis by Ramakrishnan 
et al., in which they showed that the autophagic response could be a novel target for 
inhibiting pathological angiogenesis through studying the effective mechanism of 
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kringle 5, a potent angiogenesis inhibitors. 15 
To further investigate the role of autophagy on angiogenesis, we carefully 
investigated the angiogenesis process after chick YSM and CAM were exposed to 
RAPA and 3-MA at different developmental stage of angiogenesis. The intuitive 
images of blood vessel plexus extension on YSM demonstrated that the angiogenesis 
was accelerated by exposing to RAPA, autophagy inducer; and was restricted by 
exposing to 3-MA, autophagy inhibitor (Fig. 3A-I). Using chick CAM model, we 
found the similar experimental results as it was in YSM (Fig. 4A-E) after confirming 
the cell autophagy manipulation by the altered ratios of LC3II and LC3I following the 
treatment of 3-MA/RAPA, indicating that 3-MA/RAPA exposure lead to the 
disturbance of autophagy (Fig. 4F), and RAPA-induced enhancement of angiogenesis 
showed the dose-dependent manner below 80nM (Supplementary Fig. 3A-F). 
Meanwhile, exposing to RAPA at both chick YSM and CAM increased the 
expressions of HIF 2ɑ and angiogenesis-related genes including ANG1, ANG2, TEK, 
FGF2, VE-Cadherin, VEGFA, VEGFR1-3, while exposing to 3-MA, their expression 
were inhibited at both angiogenesis models (Fig. 3J)(Fig. 4G)(Supplementary Fig. 2) 
(Supplementary Fig. 4). Promoting autophagy by tunicamycin in the CAM leads to 
the similar results to the RAPA treatment. It suggests that the alteration of 
angiogenesis in presence of RAPA/3-MA/tunicamycin could be due to the fact that 
interference with autophagy changed the expression levels of angiogenesis-related 
genes. Or it could also be the result of activation/degradation of hypoxia-inducible 
factor (HIF), the proangiogenic factor, by autophagy inducer/inhibitor since HIF 2ɑ 
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could act as a hypoxia-inducible transcription factor involved in vascular remodeling. 
30  
We speculated that the reason for the hemorrhage at RAPA/3-MA-treated embryos 
was that the integrity of blood vessels was damaged during vasculature formation. To 
address this pathologic cause, we carried out the Evans blue perfusion experiments at 
chick CAM, and found that there were leaks from the blood vessels treated with either 
RAPA or 3-MA (Fig 5A-C1), implying the imperfection of blood vessels following 
the treatments of autophagy interference. As we know, maintaining the integrity of 
blood vessel relies on the endothelial cell-cell junctions including tight junctions, 
desmosome and adherens junctions etc. 28 In the current study, electronic microscopy 
showed the increased numbers of bigger clefts between epithelial cells in either RAPA 
or 3-MA-treated CAM vessels (Fig. 5E-G), and the expressions of corresponding tight 
junction genes and adherens junction genes were also altered by the treatments of 
autophagy inducer or inhibitor (Fig. 5K). This suggests that the autophagy 
inducer/inhibitor-induced tight/adherens junction and desmosome gene expression 
alteration might interfere with the formation of vessel endothelial cell integrity, so that 
hemorrhage occurred in RAPA/3-MA-treated embryos.  
Given all that, it seems that the problem happens on endothelial cells of blood 
vessels. Using HUVECs (human umbilical vein endothelial cells) model, we tried to 
explore the effect of autophagy on endothelial cell biology. RAPA treatment could 
increased LC3 expression and completely restricted the enhanced LC3 expression 
after adding 3-MA at HUVECs (Fig. 6A-C1), and the ratio of LC3II/LC3I and the 
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expressions of other autophagy-related genes (Atg7, Beclin1, mTOR, P62) changed 
with RAPA/3-MA at time-dependent manner (Fig. 6D-E), indicating that autophagy 
level in the HUVECs could change with the treatment of autophagy inducer and 
inhibitor. In such case, scratch test demonstrated that autophagy inducement with 
RAPA could accelerate HUVECs migration ability, while autophagy inhibition with 
3-MA could suppress HUVECs migration ability (Fig. 7). However, this is only the 
experiment that reflects the cell viability of HUVECs. To further confirm the 
possibility of autophagy involvement in angiogenesis, we assessed the tube formation 
ability of HUVECs after knocking-down Atg7 gene and over-expression Atg5, Atg7, 
Atg8 in HUVECs with tube formation assay. Generally, knock-down of Atg7 gene 
expression in HUVECs could suppress the tube formation ability, so could 
overexpressed of Atg5, Atg7 and Atg8 in HUVECs (Fig. 8), which directly indicates 
that autophagy is involved in the tube formation in vitro, the similar process in vivo – 
angiogenesis. For both cell variability and cell-cell junctions, β-catenin and 
cytoskeleton such as actin play very important functions to maintain cell structure and 
support cell migration. 28 Here, we also can see that β-catenin expression is lost in 
RAPA/3-MA-treated HUVECs membrane, and cell polarity disappeared in 
comparison with control cells (Fig. 9), suggesting that autophagy interference is 
indeed able to lead to dysfunctional cytoskeleton.  
In sum, we demonstrated that autophagy-related genes express in the vascular 
plexus at chick YSA and CAM. The angiogenesis in vivo will be interfered 
dramatically when chick embryos are exposed to autophagy inducer or inhibitor. 
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Meanwhile, angiogenesis-related gene expression is in chaos as well. In such case, we 
could find hemorrhage occured in the exposed embryos as well. Further investigation 
showed that the hemorrhage occurred because of imperfection of blood vessel 
formation including damaged endothelial cell-cell junctions, endothelial cell viability 
and migration etc. Taken together, our data suggests that autophagy is indeed involved 
in the embryonic angiogenesis (Supplementary Fig. 6).  
Though there are some reports about the relationship between angiogenesis-related 
genes and epithelial-related genes. For instance, Gurnik S et. al found that ang2 could 
increase the permeability of the vascular by depressing the tight junction and 
increasing the expression of caveolin-1, another vesicular permeability-related 
molecule.31 However, ang1 and ang2 antagonized each other to modulate the 
permeability of the blood vessel, 32and the imbalance of these two gene may result in 
the lost of the permeability of the vessels no matter we inhibit autophagy or activate it. 
Like autophagy, we speculate that angiogenesis and cell junctions are all a 
balanced-process in development relying on the coordination of all of these genes. 
Up-regulation and down-regulation of some of genes may lead to a comprehensive 
result. Any disturbance in cell junctions may result in the impermeability of the 
vessels, and as some of the functions of the genes related to angiogenesis remain 
obscure, it is certain that further experimentation is required to explore the precise 
molecular biological mechanism.  
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Figure legends  
Fig 1. Atg7, Atg8 and BECN1 are expressed in chick YSM and CAM 
A-C: Immunofluorescent staining against Atg7 (A), Atg8 (B) and BECN1 (C) 
was performed on the YSM of HH13 chick embryos. A1-C1: The transverse sections 
at the sites shown with dotted lines in A-C respectively. A2-C2: DAPI staining + 
A1-C1 respectively. D-E: The transverse sections of Atg7 (D) and Atg8 (E) 
immunofluorescent staining from 10.5-day chick CAM. D1-C1: DAPI staining + D-E 
respectively. D2-C2: H&E staining on the next transverse sections of D and E 
respectively. Abbreviation: CAM, chorioallantoic membrane; YSM, yolk sac 
membrane; BECN1, beclin-1. Scale bars = 150 µm in A-C, 100 µm A1-C1, A2-C2, 
100 µm in D-E, D1-E1, D2-E2. 
Fig 2. The exposure of RAPA or 3-MA lead to hemorrhage in developing chick 
embryos.  
A-B: The representive images showing the cranial regions of 9-day control (0.1% 
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DMSO) (A), RAPA-treated (B) and 3-MA-treated (C) chick embryos respectively. 
A1-C1: The H&E staining on the transverse sections at the levels indicated by white 
dotted lines in A-C respectively. A2-C2: The schematical drawings show the 
correlation between red blood cells and blood vessels among the different groups. D: 
The bar chart showing the comparison of phenotype incidences among control, 
RAPA-treated and 3-MA-treated groups. F-G: The transmission electronic 
microscope images from control (A1) and RAPA- or (B1)3-MA-treated groups (C1). 
F1-G1: The high magnification images from E-G respectively. Abbreviation: RAPA, 
rapamycin; 3-MA, 3-Methyladenine; DMSO, dimethyl sulfoxide. Scale bars = 5 mm 
in A-C, 50 µm in A1-C1, 0.6 µm in E-G and 2.5 µm in E1-G1. 
Fig 3. The 3-MA exposure reduces and RAPA exposure promotes angiogenesis in 
chick YSM.  
A-C: The representive images of leading edges of vessel plexuses within silicon 
rings at 0 hour from control (0.1% DMSO) (A), RAPA-treated (B) and 3-MA-treated 
(C) YSM respectively. A1-C1, A2-C2, A3-C3: The representive images at 12-hour, 
24-hour, 36-hour incubation respectively. D-F: The transverse sections at the levels 
indicated by white dotted lines in A3-C3 respectively. D1-F1: The high magnification 
images from D-F respectively. G-I: The bar charts showing the comparison of blood 
vessel densities, numbers, depths among control, RAPA-treated and 3-MA-treated 
groups. J: The RT-PCR data showing the expressions of TEK, VE-Cad, HIF 2ɑ, FGF2, 
VEGFA, VEGFR1, VEGFR2, VEGFR3, ANG1 and ANG2 in control (0.1% DMSO), 
RAPA-treated and 3-MA-treated YSM tissues. Abbreviation: VE-Cad, VE-cadherin. 
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Scale bars = 2.5 mm in A-C, A1-C1, A2-C2, A3-C3; 200 µm in D-F and 100 µm in 
D1-F1. 
Fig 4. The 3-MA exposure reduces and RAPA exposure promotes angiogenesis in 
chick CAM.  
A-B: The representive images of vessel plexuses in CAM, which were treated 
with DMSO (control, A), RAPA (B) and 3-MA (C) for 2 days. D-E: The bar chart 
showing the comparison of blood vessel densities and diameters among control, 
RAPA-treated and 3-MA-treated groups. F: Western blot data showing the 
expressions of LC3-Ι and LC3-ΙΙ following the treatments of RAPA and 3-MA. G: 
The RT-PCR data showing the expressions of HIF 2α, ANG1, ANG2, VEGFA, TEK, 
VE-Cadherin, FGF2, VEGFR1, VEGFR2 and VEGFR3 in control, RAPA-treated and 
3-MA-treated CAM tissues. Scale bars = 1 cm in A-C and 3 mm in A1-C1.  
Fig 5. Both exposures of RAPA and 3-MA restrict the integrality of endothelium in 
YSM and CAM.  
A-C: The representative fluorescent images of blood vessels in YSM of 3-day 
incubated embryos from control (A), RAPA-treated (B) and 3-MA-treated (C) groups. 
The photographs were taken after two hours following the injection of Evans blue. 
A1-C1: The bright field images of A-C respectively. E-G: The transmission electronic 
microscope images from control and RAPA- or 3-MA-treated groups. G: The bar 
chart showing the comparison of evans blue contents among control, RAPA-treated 
and 3-MA-treated groups. H-J: The β-catenin immunofluorescent staining was 
performed on the transverse sections in the cranial regions of the 9d chick embryos 
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control (H), RAPA-treated (I) and 3-MA-treated (J) groups respectively. K: The 
RT-PCR data showing the expressions of Claudin-1, Claudin-5, Claudin-12, Occludin, 
ZO1, ZO2, α-catnin, Vinculin, CGN, Par3, CGN, P120, Plakoglobin, Desmoplakin 
and PPIA in control (0.1% DMSO), RAPA-treated and 3-MA-treated YSM tissues. 
Abbreviation: ZA, Zonula adherens. Scale bars = 300 µm A-C, A1-C1, 1 µm in E-G 
and 20 µm in E-G.  
Fig 6. The exposure of RAPA promotes LC3 expression in cultured HUVECs. 
A-C: The LC3 immunofluorescent staining was performed on 8-hour exposed 
HUVECs with 0.1% DMSO (control) (A), RAPA (B) and RAPA+3-MA. A1-C1: 
DAPI staining + A-C respectively. D: Western blot data showing the expressions of 
LC3-Ι/LC3-ΙΙ, Atg7, Beclin-1, mTOR, P62 and β-actin at 2-hour, 4-hour and 8-hour 
incubation following the treatments of RAPA. E: Western blot data showing the 
expressions of LC3-Ι/LC3-ΙΙ, Atg7, Beclin-1, mTOR, P62 and β-actin at 2-hour, 
4-hour and 8-hour incubation following the treatments of 3-MA. Abbreviation: 
HUVECs, human umbilical vein endothelial cells. Scale bars = 20 µm in A-C, A1-C1. 
Fig 7. The exposure of 3-MA suppresses, but RAPA doesn’t affect HUVECs cell 
migration in scratch test.  
A-C: The representative images of HUVECs scratch test at 0-hour incubation 
from control (A), 3-MA-treated (B) and RAPA-treated (C) groups respectively. 
A1-C1, A2-C2, A3-C3: The representative images of HUVECs scratch test at 12-hour 
(A1-C1), 24-hour (A2-C2) and 48-hour (A3-B3) incubation from control (A1-A3), 
3-MA-treated (B1-B3) and RAPA-treated (C1-C3) groups respectively. D: The graph 
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showing the distances of HUVEC cell migration along with incubation time in 
presence/absence of RAPA or 3-MA. E: The graph showing the alteration of migrated 
HUVECs cell numbers along with incubation time in presence/absence of RAPA or 
3-MA. F: Western blot data showing the expressions of HIF 2ɑ, VEGFR2 and 
VEGFA following the treatments of RAPA and 3-MA. Scale bars = 100 µm in A-C, 
A1-C1, A2-C2, A3-C3 and 100 µm in A4-C4. 
Fig 8. Inhibition of ATG7 or promotion of ATG5, ATG7 and ATG8 decreased the 
capillary tube formation of HUVECs  
A-B: The bright field images of HUVECs after transfection of GFP (A) or ATG5 
(B). A1-B1: The fluorescent images of A-B. A2-B2: The bright images of tube 
formation by HUVECs expressed ATG5 (A2) and GFP (B2) steadily. C: Western blot 
data showing the expressions of ATG5 after transfection of GFP or ATG5. D: The bar 
chart showing the average tube numbers in ATG5 or GFP transfected HUVECs. E-G: 
The bright images of tube formation by HUVECs after transfection of control vector 
(E), siATG7 (F) or ATG7 (G), respectively. H: Western blot data showing the 
expressions of ATG7 after transfection of control vector, siATG7 or ATG7, 
respectively. I: The bar chart showing the average tube numbers in siATG7, ATG7 or 
control plasimids transfected HUVECs. J-K: The bright field images of HUVECs 
after transfection of GFP (J) or ATG8 (K). J1-K1: The fluorescent images of J-K. 
J2-K2: The bright images of tube formation by HUVECs expressed ATG8 (K2) and 
GFP (J2) steadily. L: Western blot data showing the expressions of ATG8 after 
transfection of GFP or ATG8. M: The bar chart showing the average tube numbers in 
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ATG8 or GFP transfected HUVECs. N-Q: The representative images of tube 
formation by HUVECs treated by 0.1% DMSO as control (N), RAPA (O) 3-MA (P) 
and RAPA+3-MA (Q) groups respectively. Scale bars = 100 µm in A-B, A1-B, 50 µm 
in A2-B2, 50 µm in E-G, 100 µm in J-K, J1-K1, 50 µm in J2-K2 and 60 µm in N-Q. 
Fig 9. Both exposures of RAPA and 3-MA impaired the integrality of HUVECs 
A-C: The F-actin immunofluorescent staining was performed on the HUVECs after 
8-hour incubation of 0.1% DMSO as control (A), RAPA-treated (B) and 
3-MA-treated (C) groups respectively. D-F: The representative β-catenin fluorescent 
images + DAPI staining of HUVECs after 8-hour incubation of 0.1% DMSO as 
control (D), RAPA-treated (E) and 3-MA-treated (F) groups respectively. G: The 
RT-PCR data showing the expressions of Plakoglobin, β-catnin and GAPDH. Scale 
bars = 20 µm in A-C and 30 µm in D-F. 
Supplementary Fig 1. The sets of primers used for PCR in this study. 
Supplementary Fig 2. The bar chart showing the comparisons of gene expressions 
in Fig 3J. 
Supplementary Fig 3. The exposure of various concentrations of RAPA uphold 
angiogenesis in chick CAM. 
A-D: The representive images of vessel plexuses in CAM, which were treated 
with 0.1% DMSO (control, A), 20nM (B), 40nM (C) and 80nM (D) RAPA for 2 days. 
A1-D1, A2-D2: The representive high magnification images from the sites indicated 
by dotted squares in A-D respectively. A3-D3: The H&E stained transverse sections at 
the levels indicated by dotted lines in A1-D1 respectively. E: The bar chart showing 
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the comparison of blood vessel densities in CAM following the treatments with 
different concentrations of RAPA. F: The bar chart showing the comparison of blood 
vessel diameter in CAM following the treatments with different concentrations of 
RAPA. G: The RT-PCR data showing the expressions of VEGFR2, VEGFA, ANG1, 
ANG2 and HIF 2ɑ in CAM following the treatments with different concentrations of 
RAPA. Scale bars = 1 cm in A-D; 400 µm in A1-D1, A2-D2 and 500 µm in A3-D3. 
Supplementary Fig 4. The bar chart showing the comparisons of gene expressions 
in Fig 4G. 
Supplementary Fig 5. The exposure of tunicamycin increases angiogenesis in chick 
CAM. 
A-B: The representive images of vessel plexuses in CAM, which were treated 
with 0.1% DMSO (control, A) or 1μg/mL tunicamycin (B) for 2 days. A1-B1: The 
representive high magnification images from the sites indicated by dotted squares in 
A-B respectively. C: The bar chart showing the comparison of blood vessel densities 
in CAM following the treatments of tunicamycin. D: The RT-PCR data showing the 
expressions of Atg7, HIF 2α, VEGF and VEGFR2 in CAM following the treatments 
with tunicamycin. Scale bars = 1 cm in A-B and 4 mm in A1-B1.  
Supplementary Fig 6. Proposed mechanism for autophagy-involved in regulating 
embryonic angiogenesis. 
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